I would hope so, but going against the sector is all the political uncertainty coming out of the USA. It looks like none of the FDA staff that deal with new drugs have been cut in the latest DOGE purges, but the whole sector really needs certainty for investors to feel comfortable again.
RAC is in the very lucky position of having near equal sized markets in the USA and China. We can swing between either one if needed, but hopefully we can pursue both in parallel.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
0.015(1.22%) |
Mkt cap ! $215.4M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.23 | $106.2K | 85.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 11900 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 819 | 1 |
View Market Depth
| Last trade - 15.56pm 26/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |